$52.97
1.96% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US45332Y1091
Symbol
NARI

Inari Medical Inc Stock price

$52.97
+1.94 3.80% 1M
+5.98 12.73% 6M
-11.95 18.41% YTD
-12.83 19.50% 1Y
-38.93 42.36% 3Y
+10.46 24.61% 5Y
+10.46 24.61% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-1.06 1.96%
ISIN
US45332Y1091
Symbol
NARI
Sector

Key metrics

Market capitalization $3.10b
Enterprise Value $3.02b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 562.79
EV/Sales (TTM) EV/Sales 5.26
P/S ratio (TTM) P/S ratio 5.40
P/B ratio (TTM) P/B ratio 7.12
Revenue growth (TTM) Revenue growth 22.41%
Revenue (TTM) Revenue $574.50m
EBIT (operating result TTM) EBIT $-32.04m
Free Cash Flow (TTM) Free Cash Flow $5.37m
Cash position $111.61m
EPS (TTM) EPS $-1.35
P/E forward negative
P/S forward 5.14
EV/Sales forward 5.01
Short interest 6.30%
Show more

Is Inari Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Inari Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Inari Medical Inc forecast:

12x Buy
71%
5x Hold
29%

Analyst Opinions

17 Analysts have issued a Inari Medical Inc forecast:

Buy
71%
Hold
29%

Financial data from Inari Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
575 575
22% 22%
100%
- Direct Costs 88 88
47% 47%
15%
487 487
19% 19%
85%
- Selling and Administrative Expenses 398 398
22% 22%
69%
- Research and Development Expense 104 104
22% 22%
18%
-15 -15
944% 944%
-3%
- Depreciation and Amortization 17 17
84% 84%
3%
EBIT (Operating Income) EBIT -32 -32
201% 201%
-6%
Net Profit -79 -79
2,737% 2,737%
-14%

In millions USD.

Don't miss a Thing! We will send you all news about Inari Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inari Medical Inc Stock News

Neutral
GlobeNewsWire
26 days ago
Reimbursement approval supports expanded access to effective, safe thrombus removal for patients suffering from deep vein thrombosis (DVT) in Japan Reimbursement approval supports expanded access to effective, safe thrombus removal for patients suffering from deep vein thrombosis (DVT) in Japan
Neutral
GlobeNewsWire
26 days ago
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced it has entered into a joint venture with 6 Dimensions Capital (“6 Dimensions”) and its successor fund 120 Capital, and VFLO Medical (“VFLO”), a medical device...
Neutral
GlobeNewsWire
2 months ago
Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization
More Inari Medical Inc News

Company Profile

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

Head office United States
CEO Andrew Hykes
Employees 1,300
Founded 2011
Website www.inarimedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today